Eugene

[email protected]

LATEST

Almac Invests $41 Million in Dundalk, Ireland Facility
By

By
Almac Group, a Craigavon, Ireland-based contract development and manufacturing organization, plans to invest £30 million ($41 million) for a quality control laboratory and packaging facility for commercial drug products and…

Celgene to Open Biopharma Incubator in New Jersey
By

By
Celgene plans to open the Thomas O. Daniel Research Incubator and Collaboration Center to provide entrepreneurs laboratory space and resources and support scientists and companies to accelerate medical discoveries and…

GE Partners in Single-Use Biomanufacturing for CAR-T Therapy
By

By
GE Healthcare has agreed to configure a biomanufacturing facility in Shanghai, China for Cellular Biomedicine Group (CBMG), a Shanghai-headquartered clinical-stage biopharmaceutical company focused on cancer immunotherapies and stem-cell therapies for…

Ipca To Acquire API CMO Pisgah Labs
By

By
Ipca Laboratories, a Mumbai, India-based supplier of active pharmaceutical ingredients and drug products, has agreed to acquire Pisgah Labs, a Pisgah Forest, North Carolina-headquartered contract services provider. Pisgah Labs was…

Pfizer, Kite Pharma in Cancer Clinical Trial Pact
By

By
Pfizer has formed a clinical trial collaboration with Kite Pharma, Gilead Sciences’ cell-therapy subsidiary, to evaluate the investigational combination of Gilead’s Yescarta (axicabtagene ciloleucel), a chimeric antigen receptor T cell…

Novartis, Biocon in Biosimilars Pact
By

By
Sandoz, the generics arm of Novartis, has partnered with Biocon, a Bangalore, India-based pharmaceutical company, to develop, manufacture, and commercialize multiple biosimilars in immunology and oncology. Under the agreement, both…

Celgene To Acquire Juno Therapeutics for $9 Billion
By

By
Celgene has agreed to acquire Juno Therapeutics, a Seattle, Washington biopharmaceutical company developing cancer immunotherapies, for approximately $9 billion. Under the agreement, Celgene will pay $87 per share in cash,…

Sanofi To Acquire Biogen Spin-off Bioverativ for $11.6 Billion
By

By
Sanofi has agreed to acquire Bioverativ, a Waltham, Massachusetts-headquartered company created from the spin-off of Biogen’s hemophilia business, for approximately $11.6 billion. The transaction was unanimously approved by both Sanofi’s…

US Hospitals Plan to Develop Not-for-profit Generic-Drug Company
By

By
Intermountain Healthcare, a not-for-profit health system, has partnered with several similar health systems— Ascension, SSM Health, and Trinity Health—in consultation with the US Department of Veterans Affairs, to form a…

MHRA Issues Update to Pharma Companies on Brexit Preparations
By

By
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued an update for pharmaceutical companies on scenarios regarding pharmaceutical regulation dependent on the implementation plan of the UK exiting…